CLLS logo

Cellectis S.A. (CLLS)

Profile

Full Name

Cellectis S.A.

Ticker

NASDAQ: CLLS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

March 24, 2015

Indexes

Not included

Website

https://www.cellectis.com

Employees

216

Key Details

Price

$2.57(-1.04%)

Market cap

$258.14M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$41.43M(+5387.64% YoY)

Annual EPS

$0.00(+100.00% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.57
    CLLS price is $2.57

    30-Day Relative Volume

    0.17
    CLLS 30-day relative volume is 0.17

    Price Performance

    Price Most recent change

    -1.04%
    CLLS price was down -1.04% on Aug 29, 2025

    Price YTD change

    +42.94%
    CLLS price is up +42.94% since January 1st

    Price 1-year change

    +7.21%
    CLLS price is up +7.21% year-on-year

    Price 3-year change

    -22.03%
    CLLS price is down -22.03% over the past 3 years

    Price Range

    Price All-time high

    $50.00
    CLLS price is currently -94.85% below its historical high of $50.00

    Price 3-year low

    $0.96
    CLLS price is currently +167.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $258.14M
    CLLS market capitalization is $258.14 million

    Market cap 3-year change

    +71.88%
    CLLS market capitalization is up +71.88% over the past 3 years

    Market cap All-time high

    $1.48B
    CLLS market capitalization is currently -82.53% below its historical high of $1.48 billion

    Market cap sector rank

    55.22%
    CLLS market capitalization is higher than 55.22% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.23%
    CLLS shares outstanding is up +0.23% year-on-year

    Shares Outstanding 3-Year Change

    +120.44%
    CLLS shares outstanding is up +120.44% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.57
    CLLS beta is 0.57

    200-day SMA

    $1.73
    CLLS price is currently +49.11% above its 200-day simple moving average

    50-day SMA

    $2.25
    CLLS price is currently +14.57% above its 50-day simple moving average

    RSI

    49.53
    CLLS 14-day relative strength index is 49.53

    Volume

    0.17
    CLLS 30-day relative volume is 0.17

    ATR

    $0.20
    CLLS average true range is $0.20

    10-day Historical Volatility

    54.10%
    CLLS 10-day historical volatility is 54.10%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $41.43M
    CLLS annual revenue is $41.43 million

    Revenue Analysts estimate

    $39.49M
    CLLS annual revenue is currently +4.92% higher than the consensus analysts' forecast

    Revenue 1-year change

    +5387.64%
    CLLS annual revenue is up +5387.64% year-on-year

    Revenue Sector rank

    60.16%
    CLLS annual revenue is higher than 60.16% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    CLLS annual earnings per share is $0.00

    EPS Analysts estimate

    -$0.61
    CLLS annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    +100%
    CLLS annual earnings per share is up +100% year-on-year

    EPS Sector rank

    82.48%
    CLLS annual earnings per share is higher than 82.48% of companies in Healthcare sector

    Profit

    Gross profit

    $21.59M
    CLLS annual gross profit is $21.59 million

    Gross margin

    52.12%
    CLLS annual gross profit margin is 52.12%

    Operating profit

    -$68.00M
    CLLS annual operating income is -$68.00 million

    Operating margin

    -212.00%
    CLLS annual operating profit margin is -212.00%

    Net income

    -$36.70M
    CLLS annual net profit is -$36.70 million

    Net margin

    -88.57%
    CLLS annual net profit margin is -88.57%

    Expenses

    Total expenses

    $78.13M
    CLLS annual total expenses is $78.13 million

    Operating expenses

    $89.59M
    CLLS annual total operating expenses is $89.59 million

    Cost of goods sold

    $19.84M
    CLLS annual cost of goods sold is $19.84 million

    Selling, general & administrative expenses

    $0.00
    CLLS annual SGA is $0.00

    Depreciation and amortization

    $19.81M
    CLLS annual depreciation & amortization is $19.81 million

    Interest expense

    $0.00
    CLLS annual interest expense is $0.00

    Income tax

    -$6.44M
    CLLS annual income tax is -$6.44 million

    EBIT & EBITDA

    EBIT

    -$68.00M
    CLLS annual earnings before interest & taxes is -$68.00 million

    EBITDA

    -$48.16M
    CLLS annual EBITDA is -$48.16 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $392.55M
    CLLS annual total assets is $392.55 million

    Non current assets

    $96.48M
    CLLS annual long term assets is $96.48 million

    Current assets

    $287.07M
    CLLS annual total current assets is $287.07 million

    Cash and cash equivalents

    $260.31M
    CLLS annual cash & cash equivalents is $260.31 million

    Accounts receivable

    $6.71M
    CLLS annual accounts receivable is $6.71 million

    Inventory

    $0.00
    CLLS annual inventory is $0.00

    Liabilities

    Total liabilities

    $261.52M
    CLLS annual total liabilities is $261.52 million

    Long term liabilities

    $10.12M
    CLLS annual total long term liabilities is $10.12 million

    Current liabilities

    $166.27M
    CLLS annual total current liabilities is $166.27 million

    Accounts payable

    $18.66M
    CLLS annual accounts payable is $18.66 million

    Debt

    Total debt

    $109.65M
    CLLS annual total debt is $109.65 million

    Total debt 1-year change

    +18.09%
    CLLS annual total debt is up +18.09% year-on-year

    Long term debt

    $85.13M
    CLLS annual long term debt is $85.13 million

    Short term debt

    $24.52M
    CLLS annual short term debt is $24.52 million

    Equity & Capital

    Shareholders equity

    $131.03M
    CLLS annual stockholders equity is $131.03 million

    Book value

    $94.38M
    CLLS annual book value is $94.38 million

    Retained earnings

    -$329.61M
    CLLS annual retained earnings is -$329.61 million

    Working capital

    $120.80M
    CLLS annual working capital is $120.80 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $22.10M
    CLLS annual cash flow from operations is $22.10 million

    Cash from operations 1-year change

    +188.13%
    CLLS annual cash flow from operations is up +188.13% year-on-year

    Cash from investing

    -$102.63M
    CLLS annual cash flow from investing activities is -$102.63 million

    Cash from investing 1-year change

    -561.68%
    CLLS annual cash flow from investing activities is down -561.68% year-on-year

    Cash from financing

    $89.80M
    CLLS annual cash flow from financing activities is $89.80 million

    Cash from financing 1-year change

    +7.94%
    CLLS annual cash flow from financing activities is up +7.94% year-on-year

    CAPEX

    CAPEX

    $3.84M
    CLLS annual capital expenditures is $3.84 million

    CAPEX 1-year change

    +257.52%
    CLLS annual capital expenditures is up +257.52% year-on-year

    Free Cash Flow

    Free cash flow

    $18.27M
    CLLS annual free cash flow is $18.27 million

    Free cash flow 1-year change

    +169.85%
    CLLS annual free cash flow is up +169.85% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    52.12%
    CLLS annual gross profit margin is 52.12%

    Operating margin

    -212.00%
    CLLS annual operating profit margin is -212.00%

    Net margin

    -88.57%
    CLLS annual net profit margin is -88.57%

    ROA & ROE

    ROA

    -10.10%
    CLLS annual return on assets is -10.10%

    ROE

    -34.02%
    CLLS annual return on equity is -34.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CLLS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CLLS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.66
    CLLS price to book ratio is 2.66

    PB ratio Sector rank

    62.09%
    CLLS price to book ratio is higher than 62.09% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.58
    CLLS price to sales ratio is 4.58

    PS ratio Sector rank

    57.18%
    CLLS price to sales ratio is higher than 57.18% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $312.15M
    CLLS enterprise value is $312.15 million

    Enterprise value Sector rank

    61.55%
    CLLS enterprise value is higher than 61.55% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.51
    CLLS EV/EBITDA is -9.51

    EV/EBITDA Sector rank

    13.1%
    CLLS EV/EBITDA is higher than 13.1% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.73
    CLLS annual current ratio is 1.73

    Quick ratio

    1.73
    CLLS annual quick ratio is 1.73

    Leverage

    Debt to equity

    0.84
    CLLS annual debt to equity ratio is 0.84

    Interest coverage ratio

    -
    CLLS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    CLLS piotroski f-score is 4

    Altman Z-Score

    -0.68
    CLLS altman z-score is -0.68

    Analyst ratings

    Recent major analysts updates

    May 13, 25 Barclays
    Overweight
    Nov 5, 24 Barclays
    Overweight
    Jun 12, 24 Oppenheimer
    Outperform
    May 31, 24 JMP Securities
    Market Outperform
    Nov 1, 23 JMP Securities
    Market Outperform
    Aug 8, 23 Oppenheimer
    Outperform
    Aug 7, 23 JMP Securities
    Market Outperform
    Apr 5, 23 Citigroup
    Buy
    Mar 13, 23 Oppenheimer
    Outperform
    Mar 13, 23 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with CLLS included

    Growing Shares Outstanding
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Cellectis S.A.?
    • Does Cellectis S.A. pay dividends?
    • What sector is Cellectis S.A. in?
    • What industry is Cellectis S.A. in?
    • What country is Cellectis S.A. based in?
    • When did Cellectis S.A. go public?
    • Is Cellectis S.A. in the S&P 500?
    • Is Cellectis S.A. in the NASDAQ 100?
    • Is Cellectis S.A. in the Dow Jones?
    • When was Cellectis S.A.'s last earnings report?
    • When does Cellectis S.A. report earnings?

    What is the ticker symbol for Cellectis S.A.?

    The ticker symbol for Cellectis S.A. is NASDAQ:CLLS

    Does Cellectis S.A. pay dividends?

    No, Cellectis S.A. does not pay dividends

    What sector is Cellectis S.A. in?

    Cellectis S.A. is in the Healthcare sector

    What industry is Cellectis S.A. in?

    Cellectis S.A. is in the Biotechnology industry

    What country is Cellectis S.A. based in?

    Cellectis S.A. is headquartered in France

    When did Cellectis S.A. go public?

    Cellectis S.A.'s initial public offering (IPO) was on March 24, 2015

    Is Cellectis S.A. in the S&P 500?

    No, Cellectis S.A. is not included in the S&P 500 index

    Is Cellectis S.A. in the NASDAQ 100?

    No, Cellectis S.A. is not included in the NASDAQ 100 index

    Is Cellectis S.A. in the Dow Jones?

    No, Cellectis S.A. is not included in the Dow Jones index

    When was Cellectis S.A.'s last earnings report?

    Cellectis S.A.'s most recent earnings report was on May 6, 2025

    When does Cellectis S.A. report earnings?

    The next expected earnings date for Cellectis S.A. is November 10, 2025
    On this page